Researchers sought to determine 1-year outcomes in patients being treated with tirzepatide who have atrial fibrillation.

There are improved all-cause mortality, rhythm control, and adverse cardiac event outcomes in patients being treated with tirzepatide who have atrial fibrillation. Patients with atrial ...

Oral semaglutide (Rybelsus) can be tied to a near halving of incident Afib, according to a meta-analysis of 26 randomized ...

The caveat here is that if one is opting for rhythm control to avoid the need for warfarin in this elderly population, that is not a valid assumption. How should one manage atrial fibrillation ...

Accounting for mortality as competing risk, the Afib burden trended numerically in favor of the GLP-1 RA group (HR 0.85, 95% ...

The consistency of these findings is truly remarkable if one considers that the rhythm-control approach has been the preferred treatment modality used in clinical practice and is associated with ...

Stroke, one of the most severe complications of atrial fibrillation (AF), can be prevented by oral anticoagulants in patients ...

Boston Scientific today shared new clinical data supporting multiple therapies at the Heart Rhythm Society (HRS) 2025 Meeting ...

a “rate control” strategy and a “rhythm control” strategy. In 2002, the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) randomized trial evaluated the outcomes of ...

A smartwatch can detect abnormal ventricular beats known as premature ventricular contractions which can warn you of AFib.

Canada-based Kardium has revealed positive one-year efficacy results on its pulsed field ablation (PFA) device, the Globe PF ...